VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). H. Lundbeck A/S...
Read More Details
Finally We wish PressBee provided you with enough information of ( Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan )
Also on site :
- Russia reliable partner to Africa in strengthening sovereignty – Lavrov
- Ship carrying oil and hazardous cargo sinks off Kerala coast
- Trump’s talk on Ukraine is cheap, but the Kremlin has set him a pivotal test